Kinase inhibitors (KIs) represent a growing class of drugs directed at various protein kinases
and used in the treatment of both solid tumors and hematologic malignancies. It is a …

Cardiovascular complications after radiotherapy Page 1 Address for correspondence: Izabela
Nabiałek-Trojanowska, MD, Department of Cardiology, Medical University of Gdansk, ul. Dębinki …

Simple Summary Trastuzumab administered as a (neo) adjuvant therapy in radically treated
Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast cancer patients …

Abstract Purpose of Review This study aims to assess the current state of cardio-oncology in
reference to advocacy efforts, access to care, and perspective of stakeholders in their ability …

Simple Summary Lung cancer is characterized by a high mortality rate. The main prognostic
factors are histopathological and molecular diagnosis as well as clinical advancement …

Cardiovascular diseases (CVDs) are the major cause of morbidity/mortality among breast
cancer (BC) patients. Observation of the daily practice in eight experienced Polish oncology …

Background Algorithm of anthracycline-based chemotherapy with favourable cardio-
oncological outcome should be clearly re-defined for lymphoma patients with significant pre …

Background Breast cancer is one of the most common cancers in women. The aim of the
study was a comparative analysis of the level of knowledge of third-to fifth-year …

Anticancer treatment with the human epidermal growth factor receptor (HER) 2 inhibitors can
lead to significant myocardial dysfunction. The primary aim of the study was to estimate the …

Pulmonary arterial hypertension (PAH) seems to be a rare and specific complication of
treatment with dasatinib [1]. It is diagnosed relatively late, several months after the start of …